Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. N10630A30

FosB/G0S3 Antibody (83B1138), Alexa Fluor™ 350, Novus Biologicals™
SDP

Catalog No. N10630A30 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
N10630A30 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. N10630A30 Supplier Novus Biologicals Supplier No. NB10056530AF350
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

FosB/G0S3 Monoclonal specifically detects FosB/G0S3 in Human samples. It is validated for Western Blot.

Specifications

Antigen FosB/G0S3
Applications Western Blot
Classification Monoclonal
Clone 83B1138
Conjugate Alexa Fluor 350
Dilution Western Blot
Formulation 50 mM sodium borate with 0.05% sodium azide
Gene Alias activator protein 1, AP-1, DKFZp686C0818, FBJ murine osteosarcoma viral oncogene homolog B, G0S3G0/G1 switch regulatory protein 3, GOS3, GOSB, MGC42291, oncogene FOS-B, protein fosB
Gene Symbols FOSB
Host Species Mouse
Immunogen This antibody was generated by immunizing mice with a synthetic peptide corresponding to amino acids 2-15 of human FosB.
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 2354
Target Species Human
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.